Crescent Biopharma Inc - Company Profile
Powered by 
All the sales intelligence you need on Crescent Biopharma Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Crescent Biopharma Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Crescent Biopharma Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Crescent Biopharma Inc (Crescent Biopharma), formerly GlycoMimetics Inc, is a clinical-stage biotechnology company that discovers, develops, and markets novel glycomimetic therapeutics. Proprietary technology, research and development activities, and lead product candidate named CR-001 are its strengths even as a history of operating losses is a major cause of concern for the company. Although rapid technological changes, intense competition, and stringent regulations could negatively impact the company's growth prospects. Crescent Biopharma could benefit from their innovative product pipeline, strategic agreements, and the growing incidence of cancer.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer